Sign In
Buy A
$138.37
-0.340 (-0.245%)
At Close: Jul 31, 2026
Agilent Q1 Earnings Miss Estimates, Revenues Up Y/Y, Shares Fall
01:55pm, Thursday, 26'th Feb 2026
A posts Q1 revenue growth and beats sales estimates, but margin pressure and earnings miss send shares lower in pre-market trade.
Agilent Technologies, Inc. (A) Q1 2026 Earnings Call Transcript
11:37pm, Wednesday, 25'th Feb 2026
Agilent Technologies, Inc. (A) Q1 2026 Earnings Call Transcript
Agilent (A) Reports Q1 Earnings: What Key Metrics Have to Say
09:01pm, Wednesday, 25'th Feb 2026
While the top- and bottom-line numbers for Agilent (A) give a sense of how the business performed in the quarter ended January 2026, it could be worth looking at how some of its key metrics compare to
Agilent Technologies (A) Lags Q1 Earnings and Revenue Estimates
08:25pm, Wednesday, 25'th Feb 2026
Agilent Technologies (A) came out with quarterly earnings of $1.36 per share, missing the Zacks Consensus Estimate of $1.37 per share. This compares to earnings of $1.31 per share a year ago.
Agilent reports in-line first quarter, says results hurt by US snowstorm
05:24pm, Wednesday, 25'th Feb 2026
Life sciences firm Agilent Technologies on Wednesday reported first-quarter results that were largely in line with Wall Street estimates on stable demand for its medical tools and equipment used in la
Agilent Reports First-Quarter Fiscal Year 2026 Financial Results
04:05pm, Wednesday, 25'th Feb 2026
SANTA CLARA, Calif.--(BUSINESS WIRE)---- $A #CustomerFirst--Agilent Technologies, Inc. (NYSE: A) today reported revenue of $1.80 billion for the first quarter ended Jan. 31, 2026, representing growth
Agilent to Participate in TD Cowen's 46th Annual Health Care Conference
04:15pm, Monday, 23'rd Feb 2026
SANTA CLARA, Calif.--(BUSINESS WIRE)---- $A #BringGreatScienceToLife--Agilent Technologies Inc. (NYSE: A) today announced that Chief Financial Officer Adam Elinoff and Head of Investor Relations Tejas
CenterBook Partners LP Buys Shares of 10,386 Agilent Technologies, Inc. $A
04:07am, Saturday, 21'st Feb 2026
CenterBook Partners LP acquired a new position in shares of Agilent Technologies, Inc. (NYSE: A) in the undefined quarter, according to its most recent filing with the Securities and Exchange Commissi
Stay Ahead of the Game With Agilent (A) Q1 Earnings: Wall Street's Insights on Key Metrics
10:15am, Friday, 20'th Feb 2026
Get a deeper insight into the potential performance of Agilent (A) for the quarter ended January 2026 by going beyond Wall Street's top-and-bottom-line estimates and examining the estimates for some o
Assetmark Inc. Boosts Position in Agilent Technologies, Inc. $A
03:30am, Saturday, 14'th Feb 2026
Assetmark Inc. increased its position in Agilent Technologies, Inc. (NYSE: A) by 6.2% during the undefined quarter, according to the company in its most recent disclosure with the Securities and Excha
Bloomberg's 2026 Watch List Flags 5 Ideal 'Safer' February Dividend Buys
06:33pm, Wednesday, 11'th Feb 2026
Bloomberg's 2026 Dividend Focus list highlights 16 'safer' stocks with free cash flow yields exceeding dividend yields, signaling strong dividend sustainability. Top projected net gains for 2026 inclu
Agilent Announces Cash Dividend of 25.5 Cents per Share
04:15pm, Wednesday, 11'th Feb 2026
SANTA CLARA, Calif.--(BUSINESS WIRE)--Agilent Technologies Inc. (NYSE: A) today announced a quarterly dividend of 25.5 cents per share of common stock. The quarterly dividend will be paid on April 22,
Agilent Presents Boehringer Ingelheim With Inaugural 2025 Instrument Trade‑In Impact Award
08:00am, Wednesday, 11'th Feb 2026
SANTA CLARA, Calif.--(BUSINESS WIRE)-- #CircularEconomy--Agilent Technologies Inc. (NYSE: A) today announced that Boehringer Ingelheim has been selected as the winner of Agilent's inaugural Instrument
Agilent Receives FDA Approval for PD-L1 IHC 22C3 pharmDx in Epithelial Ovarian, Fallopian Tube, or Primary Peritoneal Carcinoma (EOC)
06:45am, Wednesday, 11'th Feb 2026
SANTA CLARA, Calif.--(BUSINESS WIRE)---- $A #BringGreatScienceToLife--Agilent Technologies Inc. (NYSE: A) today announced that the U.S. Food and Drug Administration (FDA) has approved PD-L1 IHC 22C3 p
Envestnet Asset Management Inc. Raises Holdings in Agilent Technologies, Inc. $A
04:58am, Monday, 09'th Feb 2026
Envestnet Asset Management Inc. grew its stake in Agilent Technologies, Inc. (NYSE: A) by 3.8% in the undefined quarter, according to its most recent filing with the SEC. The firm owned 607,914 shares
